• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌中差异表达的可变剪接事件的系统分析及其临床意义

Systematic Analyses of the Differentially Expressed Alternative Splicing Events in Gastric Cancer and Its Clinical Significance.

作者信息

Lin Changwei, Yu Bowen, Zhang Mao, Chen Yifei, Li Liang, Zhao Deze

机构信息

School of Life Sciences, Central South University, Changsha, China.

Department of Gastrointestinal Surgery, The Third Xiangya Hospital of Central South University, Changsha, China.

出版信息

Front Genet. 2020 Nov 17;11:522831. doi: 10.3389/fgene.2020.522831. eCollection 2020.

DOI:10.3389/fgene.2020.522831
PMID:33281863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7705250/
Abstract

Accumulation of evidence has indicated a close relationship between alternative splicing (AS) and gastric cancer (GC), whereas systematic analyses of the differentially expressed AS events (DEAS) between GC and normal tissues are lacking. RNA-Seq data and the corresponding clinical information were downloaded from TCGA GC cohort. The percent spliced-in (PSI) value calculated in the GC tissues and normal tissues was employed to quantify the DEAS. Further, survival-associated DEAS and DEAS signatures were identified by univariate and multivariate cox regression analyses. To evaluate the association between DEAS and patients' clinical features, Kaplan-Meier analysis, receiver operator characteristic (ROC) curve, Cox proportional regression and nomograms incorporating the DEAS signatures were performed. DEAS and their splicing networks were finally analyzed by bioinformatics methods. In addition, we use the method of random grouping to divide the samples into the training group and the test group. The final results of the two groups are consistent. After strict filtering, a total of 44,935 AS events were identified, among which 11,141 DEAS were preliminarily screened from 5032 genes. A total of 454 DEAS was associated with OS, and 872 DEAS were associated with DFS. The final prognostic signatures were constructed from the survival-associated DEAS with an area under the receiver operating characteristic (ROC) curve (AUC) greater than 0.6. Only ES in ABI1 was simultaneously associated with OS and DFS. Finally, we identified the splicing correlation network between the prognostic splicing factors (SF) and DEAS in GC. Our study provided a systematic portrait of survival-associated DEAS in GC and uncovered splicing networks that are valuable in deciphering the underlying mechanisms of AS in GC.

摘要

越来越多的证据表明可变剪接(AS)与胃癌(GC)之间存在密切关系,然而,目前缺乏对GC组织与正常组织之间差异表达的可变剪接事件(DEAS)的系统分析。从TCGA GC队列下载了RNA-Seq数据和相应的临床信息。利用在GC组织和正常组织中计算的剪接百分率(PSI)值来量化DEAS。此外,通过单变量和多变量Cox回归分析确定了与生存相关的DEAS和DEAS特征。为了评估DEAS与患者临床特征之间的关联,进行了Kaplan-Meier分析、受试者工作特征(ROC)曲线分析、Cox比例回归分析以及纳入DEAS特征的列线图分析。最后,通过生物信息学方法分析了DEAS及其剪接网络。此外,我们采用随机分组的方法将样本分为训练组和测试组。两组的最终结果一致。经过严格筛选,共鉴定出44935个AS事件,其中从5032个基因中初步筛选出11141个DEAS。共有454个DEAS与总生存期(OS)相关,872个DEAS与无病生存期(DFS)相关。从生存相关的DEAS构建最终的预后特征,其受试者工作特征(ROC)曲线下面积(AUC)大于0.6。只有ABI1中的外显子跳过(ES)同时与OS和DFS相关。最后,我们确定了GC中预后剪接因子(SF)与DEAS之间的剪接相关网络。我们的研究提供了GC中生存相关DEAS的系统概况,并揭示了在解读GC中AS潜在机制方面有价值的剪接网络。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb7/7705250/12a12c62fcbe/fgene-11-522831-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb7/7705250/ba2d91bc8e90/fgene-11-522831-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb7/7705250/1949f7a9d869/fgene-11-522831-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb7/7705250/25bc5b0ef9bb/fgene-11-522831-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb7/7705250/e08ce252f5e5/fgene-11-522831-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb7/7705250/e29385b6ae80/fgene-11-522831-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb7/7705250/5e5d40ae5485/fgene-11-522831-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb7/7705250/12a12c62fcbe/fgene-11-522831-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb7/7705250/ba2d91bc8e90/fgene-11-522831-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb7/7705250/1949f7a9d869/fgene-11-522831-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb7/7705250/25bc5b0ef9bb/fgene-11-522831-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb7/7705250/e08ce252f5e5/fgene-11-522831-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb7/7705250/e29385b6ae80/fgene-11-522831-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb7/7705250/5e5d40ae5485/fgene-11-522831-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb7/7705250/12a12c62fcbe/fgene-11-522831-g007.jpg

相似文献

1
Systematic Analyses of the Differentially Expressed Alternative Splicing Events in Gastric Cancer and Its Clinical Significance.胃癌中差异表达的可变剪接事件的系统分析及其临床意义
Front Genet. 2020 Nov 17;11:522831. doi: 10.3389/fgene.2020.522831. eCollection 2020.
2
Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data.结直肠癌中可变剪接的特征及其临床意义:基于大规模测序数据的研究。
EBioMedicine. 2018 Oct;36:183-195. doi: 10.1016/j.ebiom.2018.09.021. Epub 2018 Sep 19.
3
Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.基于癌症基因组图谱(TCGA)和SpliceSeq数据库的胃癌预后中可变剪接特征的综合分析
Med Sci Monit. 2020 Nov 21;26:e925772. doi: 10.12659/MSM.925772.
4
Profiles of alternative splicing events in the diagnosis and prognosis of Gastric Cancer.胃癌诊断和预后中可变剪接事件的概况
J Cancer. 2021 Mar 19;12(10):2982-2992. doi: 10.7150/jca.46239. eCollection 2021.
5
The landscape of alternative splicing reveals novel events associated with tumorigenesis and the immune microenvironment in gastric cancer.替代性剪接的全景揭示了与胃癌发生和免疫微环境相关的新事件。
Aging (Albany NY). 2021 Jan 10;13(3):4317-4334. doi: 10.18632/aging.202393.
6
Profiles of alternative splicing landscape in breast cancer and their clinical significance: an integrative analysis based on large-sequencing data.乳腺癌中可变剪接图谱及其临床意义:基于大规模测序数据的综合分析
Ann Transl Med. 2021 Jan;9(1):58. doi: 10.21037/atm-20-7203.
7
Clinically relevant immune subtypes based on alternative splicing landscape of immune-related genes for lung cancer advanced PPPM approach.基于肺癌免疫相关基因可变剪接图谱的临床相关免疫亚型:先进的PPPM方法
EPMA J. 2024 May 24;15(2):345-373. doi: 10.1007/s13167-024-00366-4. eCollection 2024 Jun.
8
Genome-Wide Transcriptional Analysis Reveals Alternative Splicing Event Profiles in Hepatocellular Carcinoma and Their Prognostic Significance.全基因组转录分析揭示肝细胞癌中的可变剪接事件谱及其预后意义。
Front Genet. 2020 Aug 11;11:879. doi: 10.3389/fgene.2020.00879. eCollection 2020.
9
Systematic profiling of alternative splicing signature reveals prognostic predictor for prostate cancer.系统分析剪接变异特征揭示前列腺癌预后预测因子。
Cancer Sci. 2020 Aug;111(8):3020-3031. doi: 10.1111/cas.14525. Epub 2020 Jul 9.
10
Systematic profiling of alternative splicing in -negative gastric cancer and their clinical significance.阴性胃癌中可变剪接的系统分析及其临床意义。
Cancer Cell Int. 2020 Jun 30;20:279. doi: 10.1186/s12935-020-01368-8. eCollection 2020.

引用本文的文献

1
Adaptor protein Abelson interactor 1 in homeostasis and disease.衔接蛋白阿贝尔森相互作用蛋白1在体内平衡与疾病中的作用
Cell Commun Signal. 2024 Oct 1;22(1):468. doi: 10.1186/s12964-024-01738-z.
2
Identification of alternative splicing associated with clinical features: from pan-cancers to genitourinary tumors.与临床特征相关的可变剪接的鉴定:从泛癌到泌尿生殖系统肿瘤
Front Oncol. 2023 Sep 25;13:1249932. doi: 10.3389/fonc.2023.1249932. eCollection 2023.
3
Polyadenylate-binding protein cytoplasmic 1 mediates alternative splicing events of immune-related genes in gastric cancer cells.

本文引用的文献

1
Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling.Abi1 缺失通过 EMT 和非经典 WNT 信号通路的激活驱动前列腺肿瘤发生。
Cell Commun Signal. 2019 Sep 18;17(1):120. doi: 10.1186/s12964-019-0410-y.
2
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.Metascape 为系统水平数据集的分析提供了面向生物学家的资源。
Nat Commun. 2019 Apr 3;10(1):1523. doi: 10.1038/s41467-019-09234-6.
3
Alternative RNA Splicing as a Potential Major Source of Untapped Molecular Targets in Precision Oncology and Cancer Disparities.
多聚腺苷酸结合蛋白细胞质 1 介导胃癌细胞中免疫相关基因的可变剪接事件。
Exp Biol Med (Maywood). 2022 Nov;247(21):1907-1916. doi: 10.1177/15353702221121631. Epub 2022 Sep 12.
选择性 RNA 剪接作为精准肿瘤学和癌症差异中未开发的分子靶点的潜在主要来源。
Clin Cancer Res. 2019 May 15;25(10):2963-2968. doi: 10.1158/1078-0432.CCR-18-2445. Epub 2019 Feb 12.
4
GENCODE reference annotation for the human and mouse genomes.GENCODE 人类和小鼠基因组参考注释。
Nucleic Acids Res. 2019 Jan 8;47(D1):D766-D773. doi: 10.1093/nar/gky955.
5
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
6
miR-487a promotes progression of gastric cancer by targeting TIA1.miR-487a 通过靶向 TIA1 促进胃癌的进展。
Biochimie. 2018 Nov;154:119-126. doi: 10.1016/j.biochi.2018.08.006. Epub 2018 Aug 23.
7
Systematic Analysis of Survival-Associated Alternative Splicing Signatures in Gastrointestinal Pan-Adenocarcinomas.系统分析胃肠道胰腺腺癌中与生存相关的可变剪接特征。
EBioMedicine. 2018 Aug;34:46-60. doi: 10.1016/j.ebiom.2018.07.040. Epub 2018 Aug 18.
8
Transcriptome-wide analysis of alternative mRNA splicing signature in the diagnosis and prognosis of stomach adenocarcinoma.转录组范围内分析胃腺癌诊断和预后中的可变剪接 mRNA 特征。
Oncol Rep. 2018 Oct;40(4):2014-2022. doi: 10.3892/or.2018.6623. Epub 2018 Aug 2.
9
Germline genetic variants were interactively associated with somatic alterations in gastric cancer.胚系遗传变异与胃癌的体细胞改变存在交互关联。
Cancer Med. 2018 Aug;7(8):3912-3920. doi: 10.1002/cam4.1612. Epub 2018 Jun 20.
10
Profiling cancer-associated genetic alterations and molecular classification of cancer in Korean gastric cancer patients.韩国胃癌患者癌症相关基因改变分析及癌症分子分类
Oncotarget. 2017 Jul 22;8(41):69888-69905. doi: 10.18632/oncotarget.19435. eCollection 2017 Sep 19.